Skip to main content

Chronic Obstructive Pulmonary Disease (COPD)!


 CHRONIC ABSTRUCTIVE PULMONARY DISEASE (COPD)

Definition:

  • COPD is defined as "a disease state characterized by airflow limitation that is not fully reversible and this airflow limitation is progressive associated with abnormal inflammatory response to the noxious or gaseous particles.
  • According to Davidson, COPD is defined as " COPD is preventable and treatable disease characterized by airflow limitation that is usually progressive and is associated with enhanced chronic inflammatory response in the airways and lungs to the noxious particles.
  • According to National Institute for Health and Clinical Excellence (NICE), COPD is defined as "Airflow obstruction with reduced FEV1/FEVc is less than 0.7, if FEV1 is greater than or equal to80%; so, diagnosis of COPD should be made on the presence of symptoms".


Signs and Symptoms:

  • Shortness of breathing
  • Cough
  • Pink puffers and Blue Blotters or Smokers Cough (classical signs of COPD).

*Pink puffer is the major sign of emphysema.

*Blue blotters are a major sign of chronic bronchitis.


COPD includes Chronic Bronchitis and Emphysema

Difference Between Chronic Bronchitis and Emphysema

  • On chronic bronchitis, there is frequent cough and sputum. 
  • In emphysema, the major symptom is shortness of breath.

Emphysema is sometimes called pink puffer due to difficulty for catching air and their faces become pink for gasping air. Chronic bronchitis is often described by blue blotters which present with cough in their skin and fingertips become blue.


1.CHRONIC BRONCHITIS

Chronic bronchitis is defined as "Chronic or recurrent cough with sputum production on most of the days for at least 3 months of the year during at least 2 consecutive years."

2.EMPHYSEMA

In emphysema elastases enzyme destroy elastin. This will lead to dilatation and destruction of respiratory bronchioles, alveoli and air sacs.

Types of Emphysema:

  • On the basis of Air Entrapment: 

  1. Centrilobular Emphysema: Dilation of respiratory bronchioles, alveolar air sacs. Occurs due to a1-antitrypsin deficiency.
  2. Panacinar Emphysema: Destruction of whole acinus. It involves acinus starting from bronchioles to alveoli.


Risk Factors of COPD:

  • Smoking: 1 pack per year= No. of cigarettes smoked per day/20 *No. of years of smoking.
  • Age
  • Gender (more common in males due to higher smoking caese)
  • Occupation (industrial workers are more prone)
  • Genetic factors (a1-antitrypsin deficiency)
  • Air pollution
  • Socio-economic status
  • Airway hyper-response (allergy)
  • Proteinases/Anti-proteinases (Either increased production of proteinases or decreased production of anti-proteinases will lead to COPD.
  • Oxidative stress (Imbalance between oxidants and antioxidants. Increased acetylation of histone causes increased release of inflammatory response. The imbalance results in COPD. Acetylation process also decreases the activity of a1-antitrypsin).
  • Hypoxia (low level oxygen in tissue)
  • Hypoxemia (low level partial o2 saturation)
  • Hypercapnia (Increase level of CO2 in blood)
  • Pulmonary Involvement


Management of COPD

Management of either Stable COPD or Acute Exacerbation COPD as described by NICE Guidelines stepwise approach.

Stable COPD

  1. Nicotine Replacement Therapy is highly recommended.
  2. Weak bronchodilators: Theophylline (we can use sustained release theophylline tablets). Theophylline decreases the activity of histone acetylase. Theophylline increases the activity of histone deacetylase. Reduction in the oxidative stress process. So, this drug can be used in COPD patients.
  3. Inhaled corticosteroids 
  4. Oral corticosteroids: Use possible minimum dose. 
  5. Mucolytic agents: can be used in chronic COPD. Used in patients of stable COPD having increased cough with sputum.
  6. Antibiotics: Erythromycin, Doxycycline is used in patients of chronic COPD.


Acute Exacerbations

  1. Bronchodilators:  Metered Dose Inhalers and B2 agonists can be given with or without anticholinergic drugs depending upon situation.
  2. Antibiotics: Penicillin, Macrolides, Oxytetracyclines
  3. Corticosteroids
  4. IV Aminophylline
  5. Oxygen therapy (Long term oxygen therapy LTOT)
  6. Nicotine Replacement Therapy (NRT): Varenicline and Bupropion are the two recommended drugs used as replacement of nicotine therapy.

  • Transdermal Patches: Not applied on broken skin. These patches effects remain for 24hours (long time) and are used as once daily dose. However, patients may cause local skin irritation, Insomnia. 
  • Gums: 2-4mg. Headaches, burning sensation, sore throat is reported with gums.
  • Sub-lingual tablets: Effect occurs within 2-3 seconds.
  • Lozenges: 1/2/4mg. Lozenges should be placed between gums and cheeks. Cough problems are reported with these.
  • Inhalers/Nasal sprays: 10mg or as required of inhalers. Nasal sprays are recommended usually as 1 spray to each nostril.


Non-Pharmacological Therapy

  1. Advice patients to stop smoking.
  2. Nutritional assessment should be taken.
  3. Preventing excessive exercise (to reduce breathlessness).
  4. Strength training for upper and lower limbs.
  5. Breathing training.
  6. Counselling about their medicine and nutrition.
  7. Self-management plan.
  8. Psychological support.

Comments

Popular posts from this blog

Diabetes Mellitus: Types!

TYPES OF DIABETES MELLITUS 1. TYPE1 DM Type 1 DM is usually diagnosed before age 30 years, but it can develop at any age. T1DM is an autoimmune disease in which insulin producing B-cells are destroyed. The presence of Human Leucocyte Antigens (HLAs ) is associated with the development of T1DM. In addition, these individuals often develop Islet cell antibodies , Insulin Autoantibodies or Glutamic Acid decarboxylase autoantibodies . At the time of development of diagnosis of T1DM, it is usually believed that most of the patients have 80-90%loss of beta cells. The remaining beta cells function at the diagnosis creates a " HONEYMOON PERIOD" during which the blood glucose levels are easier to control, and smaller amounts of insulin are required. after this, the remaining beta cells function is completely lost, and the patients become completely deficient of insulin and hence require exogenous insulin.  2. TYPE1.5 DM:  Also referred as Latent autoimmune diabetes in Adults (LAD)

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-50mg/dL and A1c level

GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD)!

MANAGEMENT OF GASTRO-ESOPHAGEAL REFLUX DISEASE  "GERD refers to the endoscopically determined esophagitis or endoscopy-negative reflux disease" . "GERD is the term used to describe any symptomatic clinical condition or histopathological alteration resulting from episodes of reflux of acid, pepsin and occasionally, bile into the esophagus from the stomach". Patients with uninvestigated "reflux-like" symptoms should be managed as patients with uninvestigated dyspepsia. There is currently no evidence that H.pylori should be investigated in patients with GERD. Symptoms: Heartburn is the characteristic symptom of GERD. Acid regurgitation Dysphagia Belching Upper abdominal discomfort Bloating and postprandial fullness Chest pain Hoarseness Cough Complications include: Esophageal ulceration Formation of specialized columnar-lined esophagus at the gastro-esophageal junction known as Barretts Esophagus . Mechanism of Acid Reflux: The mechanism of acid reflux is mu